fda_approval · nda · info
GLAXOSMITHKLINE — NDA approval: UTEBZI (unspecified)
- Event date
- 2026-06-17 00:00:00Z
- Observed
- 2026-07-09 22:53:27Z
- Source ID
- NDA215960-1
- Payload hash
- fb999bf386cc05ad6abb7dae…
Summary
GLAXOSMITHKLINE received NDA approval for UTEBZI (unspecified) on 2026-06-17. Dosage form: TABLET. Application #: NDA215960.
Entities
Informational only. Not legal, financial, or medical advice.